SAUTEBIN, LIDIA
 Distribuzione geografica
Continente #
AS - Asia 4.104
NA - Nord America 3.489
EU - Europa 3.251
SA - Sud America 564
AF - Africa 88
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.513
Nazione #
US - Stati Uniti d'America 3.357
SG - Singapore 2.351
RU - Federazione Russa 1.460
CN - Cina 725
BR - Brasile 460
HK - Hong Kong 430
UA - Ucraina 420
IT - Italia 376
VN - Vietnam 349
DE - Germania 247
FI - Finlandia 218
IE - Irlanda 156
SE - Svezia 82
CA - Canada 80
GB - Regno Unito 73
NL - Olanda 69
FR - Francia 47
IN - India 40
AR - Argentina 34
TR - Turchia 32
IQ - Iraq 30
MX - Messico 29
BD - Bangladesh 28
RS - Serbia 25
CI - Costa d'Avorio 24
ID - Indonesia 22
EC - Ecuador 20
AT - Austria 18
PL - Polonia 18
ZA - Sudafrica 18
ES - Italia 13
JP - Giappone 13
VE - Venezuela 11
PY - Paraguay 10
CL - Cile 8
CO - Colombia 8
AU - Australia 7
MY - Malesia 7
RO - Romania 7
UZ - Uzbekistan 7
BO - Bolivia 6
IL - Israele 6
IR - Iran 6
TH - Thailandia 6
AZ - Azerbaigian 5
JM - Giamaica 5
LB - Libano 5
MA - Marocco 5
SA - Arabia Saudita 5
EG - Egitto 4
JO - Giordania 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
LY - Libia 3
PK - Pakistan 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
CD - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
GH - Ghana 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
SI - Slovenia 2
SO - Somalia 2
TG - Togo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CM - Camerun 1
CU - Cuba 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
Totale 11.483
Città #
Singapore 983
Hong Kong 429
Jacksonville 390
Chandler 377
Moscow 341
Santa Clara 244
Beijing 231
Millbury 213
Princeton 180
Dong Ket 162
Ashburn 115
Nanjing 107
Boston 100
Buffalo 87
Los Angeles 87
Wilmington 86
Ho Chi Minh City 78
Amsterdam 57
Naples 57
Ottawa 53
Hanoi 42
New York 42
Nanchang 39
The Dalles 39
Hebei 36
Redondo Beach 36
Woodbridge 35
Munich 34
São Paulo 34
Shenyang 31
Des Moines 30
Seattle 30
Dallas 25
Helsinki 25
Norwalk 25
Tianjin 25
Jiaxing 23
Belgrade 22
Brooklyn 20
Kronberg 18
Napoli 18
Rome 18
Hefei 17
Mexico City 17
Nuremberg 16
Changsha 15
Orem 15
Chennai 14
Houston 14
Milan 13
Brasília 12
Falls Church 12
Redwood City 12
Rio de Janeiro 12
Turku 12
Baghdad 11
Boardman 11
Istanbul 11
Chicago 10
Orange 10
Tübingen 10
Denver 9
Indiana 9
Johannesburg 9
San Francisco 9
Tokyo 9
Warsaw 9
Belo Horizonte 8
Florence 8
Hangzhou 8
Hanover 8
Montreal 8
Phoenix 8
Atlanta 7
Falkenstein 7
Haiphong 7
Kunming 7
London 7
Quito 7
San Jose 7
Stockholm 7
Augusta 6
Cagliari 6
Campinas 6
Guarulhos 6
Porto Alegre 6
Tashkent 6
Toronto 6
Ann Arbor 5
Caracas 5
Contagem 5
Da Nang 5
Dhaka 5
Dublin 5
Guayaquil 5
Maceió 5
Recife 5
Ribeirão Preto 5
Rimini 5
Salvador 5
Totale 5.528
Nome #
Capitolo 42 del Trattato di Farmacologia. Farmaci per la terapia della gotta 140
Regulation (EC) No. 1223/2009 on cosmetic products ('Cosmetics Regulation'): the European Cosmetovigilance System. Serious Undesirable Effects Reporting Guidelines and notification Forms 132
BRP-7, a novel benzimidazole-based chemotype targeting 5-lipoxygenase-activating protein, inhibits leukotriene biosynthesis in experimental models of acute inflammation in vivo. 110
In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis. 105
Use of Mometasone furoate in prolonged treatment of experimental spinal cord injury in mice: A comparative study of three different glucocorticoids 105
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 105
In vivo differences in leukotriene biosynthesis in zymosan-induced peritonitis: role of resident peritoneal macrophages. 101
5-ARYLIDENE-2-IMINO-4-THIAZOLIDINONES: DESIGN AND SYNTHESIS OF NOVEL ANTI-INFLAMMATORY AGENTS. 100
SLOW REACTING SUBSTANCE OF ANAPHYLAXIS ENHANCES THE GENERATION OF 12 L HYDROXY 5,8,10,14 EICOSATETRAENOIC ACID IN ISOLATED LUNGS. 100
1,5-DIARYLPYRROLE-3-ACETIC ACIDS AND ESTERS AS NOVEL CLASSES OF POTENT AND HIGHLY ELECTIVE CYCLOOXYGENASE-2 INHIBITORS. 99
LEUKOTRIENES IN HUMAN LUNG: FORMATION AND BINDING SITES. 99
IDENTIFICATION AND PARTIAL PURIFICATION OF AN ENDOTHELIAL-DERIVED RELAXING FACTOR(S) IN SERUM OF HYPERTENSIVE PREECLAMPTIC PARTURIENTS. 99
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO PLEURISY AND LUNG INJURY CAUSED BY CARRAGEENAN. 98
NITRIC OXIDE INHIBITS LEUKOCYTES MIGRATION IN RAT DERMAL PASSIVE ARTHUS REACTION AND CARRAGEENAN PLEURISY. 98
The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). 98
5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration 97
Inhibition of inducible Nitric Oxide Synthase expression by an acetonic extract from Feijoa sellowiana Berg. fruits. 97
SAR Studies on Curcumin's Pro-inflammatory Targets: Discovery of Prenylated Pyrazolocurcuminoids as Potent and Selective Novel Inhibitors of 5-Lipoxygenase. 97
BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly 96
Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. 95
ROLE OF NITRIC OXIDE ON MULTIPLE ORGANE FAILURE INDUCED BY ZYMOSAN. 93
EPIDEMIOLOGICAL STUDIES ON DIETARY LIPIDS,HUMAN PLASMA LIPIDS AND PLATELET LIPIDS AND FUNCTION. 92
Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2 92
Anti-inflammatory activity of macrolide antibiotics. 92
LIPOCORTIN AND VASOCORTIN: TWO SPECIES OF GLUCOCORTICOID INDUCED PROTEINS AFFECTING VASCULAR PERMEABILITY. 91
Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats 91
Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors 91
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 91
The role of 5-lipoxygenase and leukotrienes in shock and ischemia-reperfusion injury. 90
ARACHIDONIC ACID METABOLISM AND CYCLIC NUCLEOTIDES IN THE CNS DURING HYPOXIA. 90
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO ACUTE PANCREATITIS INDUCED BY CERULEIN. 89
The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo 89
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 88
HEALING POWER OF ALOES 85
On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficiency in vivo. 85
Synthesis and structure-activity of antisense peptides corresponding to the region for CaM-binding domain of the inducible nitric oxide synthase 84
Flow synthesis and biological studies of an analgesic adamantane derivative that inhibits P2X7-evoked glutamate release 84
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO SPLANCHNIC ARTERY OCCLUSION SHOCK. 83
CONVERSION OF ARACHIDONIC ACID BY LIPOXYGENASE AND CYCLOOXYGENASE ACTIVITIES: QUALITATIVE AND QUANTITATIVE ASPECTS. 83
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression 82
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring CholesterolEsterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo. CO-FIRST AUTHOR 81
Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. 80
Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. 80
ANTINFIAMMATORI NON STEROIDEI 79
Oxalomalate affects the inducible nitric oxide synthase expression and activity 79
HYDROGEN SULPHIDE-INDUCED MOUESE PAW EDEMA INVOLVES PHOSPHOLIPASE A2 ACTIVATION 79
Hydrogen sulphide-induced mouse paw edema involves phospholipase A2 activation. 79
The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. 78
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 77
Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage 76
17BETA-ESTRADIOL ANTINFLAMMATORY ACTIVITY IN CARRAGEENIN-INDUCED PLEURISY. 74
A MASS FRAGMENTOGRAPHIC PROCEDURE FOR THE SIMULTANEOUS DETERMINATION OF HETE AND PGF2 IN THE CENTRAL NERVOUS SYSTEM. 73
The 5-lipoxygenase inhibitor zileuton inhibits prostaglandin production by reducing arachidonic acid release: in vitro and in vivo effects. 73
A cosmetovigilance survey in Europe. 72
Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. 72
PGF2A,THROMBOXANE B2 AND HETE LEVELS IN GERBIL BRAIN CORTEX AFTER LIGATION OF COMMON CAROTID ARTERIES AND DECAPITATION. 71
Lipocortins 71
Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo. 71
Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-gamma 71
Relaxant effect of capsazepine in the isolated rat ileum 70
STIMULUS RELATED DIFFERENCES IN THE FORMATION FORMATION OF LEUKOTRIENES AND PGD2 AFTER IMMUNOLOGICAL AND NON IMMUNOLOGICAL CHALLENGE OF HUMAN LUNG PARENCHIMA "IN VITRO". 70
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males 70
ROLE OF 5-LIPOXYGENASE IN THE MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN. 69
THE ROLE OF THE PHENETHYLE ESTER OF CAFFEIC ACID ( CAPE) IN THE INHIBITION OF RAT LUNG CYCLOOXYGENASE ACTIVITY BY PROPOLIS. 69
REGULATION OF PROSTAGLANDIN GENERATION IN CARRAGEENAN-INDUCED PLEURISY BY INDUCIBLE NITRIC OXIDE SYNTHASE IN KNOCKOUT MICE 69
PROSTAGLANDINE E OSSIDO D'AZOTO COME BERSAGLI MOLECOLARI PER LA TERAPIA ANTINFIAMMATORIA 68
Healing powers of aloes 68
ANALYTICAL PROCEDURES FOR THE STUDY OF ARACHIDONIC ACID METABOLISM IN PLATELETS AND BRAIN. 67
Inhibition of microsomal prostaglandin E(2) synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. 67
Interaction between nitric oxide and prostaglandins in inflammation. 67
Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alfa by lipopolysaccharide-activated J774 macrophages. 66
ANALYSIS OF CYCLOOXYGENASE AND LIPOXYGENASE PRODUCTS IN INCUBATION MEDIA. 66
FOOD DEPRIVATION INCREASES BRAIN NITRIC OXIDE SYNTHASE AN DEPRESSES BRAIN SEROTONIN LEVELS IN RATS. 66
“La segnalazione degli eventi indesiderabili secondo il Regolamento (CE) n. 1223/2009: le linee guida e le schede di segnalazione” 66
“Il nuovo sistema di Cosmetovigilanza secondo il Regolamento 1223/2009: le iniziative del Ministero della Salute” 66
EFFECTS OF WATER DEPRIVATION AND ANGIOTENSIN II INTRACEREBROVENTRICULAR ADMINISTRATIONON BRAIN NITRIC OXIDE SYNTHASE ACTIVITY. 65
THE MODE OF ACTION OF TIARAMIDE HYDROCHLORIDE:A NEW ANTIASTHMATIC DRUG. 65
INVOLVEMENT OF NF-KB IN THE REGULATION OF CYCLOOXIGENASE-2 PROTEIN EXPRESSION IN LPS-STIMULATED J774 MACROPHAGES. 64
Analysis of toxic exposures to cosmetic products through the data base of the Poison Control Centre of the Niguarda Ca’ Granda Hospital 64
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase 64
Gender-specific regulation of 5-lipoxygenase 63
Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase. 63
Cinnamyl-3,4-Dihydroxy-{alpha}-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase. 63
"I cosmetici contraffatti e il loro impatto sulla sicurezza d’uso e sulla salute dei consumatori. Ruolo della sorveglianza e della vigilanza” 63
The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. 62
EFFECT OF THE B2-ADRENERGIC AGONIST FENOTEROL ON THE RELEASE OF LEUKOTRIENES AND PROSTAGLANDIN D2 FROM HUMAN LUNG PARENCHIMA. 61
The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity inJ774 macrophages 61
Cosmetovigilance survey: are cosmetics considered safe by consumers? 60
ANALYSIS OF FREE NICOTINIC ACID RELEASED BY A POLYMERIC PREPARATION USING A MASS FRAGMENTOGRAPHIC TECHNIQUE. 60
Adverse cosmetic events: a pilot project 60
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52) - a novel type 5-lipoxygenase inhibitor with favorable molecular pharmacology and efficacy in vivo. 60
"Nuove procedure in cosmetovigilanza: il sistema di segnalazione dell’Unione europea e il ruolo del Ministero della Salute 60
CONGENITAL DEFICIENCY OF THROMBOXANE AND PROSTACYCLIN. 59
REGULATION OF PROSTAGLANDINS PRODUCTION BY INHIBITION OF POLY(ADP-RIBOSE) SYNTHASE IN CARRAGEENIN-INDUCED PLEURISY. 59
PROTECTIVE EFFECTS OF ANTHOCYANINS FROM BLACKBERRY IN A RAT MODEL OF ACUTE LUNG INFLAMMATION. 59
ARACHIDONIC ACID METABOLISM IN THE LUNGS: EFFECT OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS. 59
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. 59
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase 59
REDUCTION OF THE MULTIPLE ORGAN INJURY AND DYSFUNCTION CAUSED BY ENDOTOXEMIA IN 5-LIPOXYGENASE KNOCKOUT MICE AND BY THE 5-LIPOXYGENASE INHIBITOR ZILEUTON. 58
PREFERENTIAL UTILIZATION OF ENDOGENOUS ARACHIDONATE BY CYCLOOXYGENASE IN INCUBATION OF HUMAN PLATELETS. 58
Totale 7.884
Categoria #
all - tutte 42.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021606 0 0 0 0 0 94 89 11 99 28 112 173
2021/2022975 13 8 6 16 1 35 15 46 172 42 202 419
2022/2023805 235 87 39 41 79 80 0 52 98 57 26 11
2023/2024534 17 87 64 27 17 19 5 64 6 9 163 56
2024/20253.687 243 308 23 31 62 239 436 188 361 383 1.079 334
2025/20263.400 720 421 608 411 1.074 166 0 0 0 0 0 0
Totale 11.726